ATE145552T1 - Zusammensetzungen mit verzögerter wirkstoffabgabe - Google Patents

Zusammensetzungen mit verzögerter wirkstoffabgabe

Info

Publication number
ATE145552T1
ATE145552T1 AT93905844T AT93905844T ATE145552T1 AT E145552 T1 ATE145552 T1 AT E145552T1 AT 93905844 T AT93905844 T AT 93905844T AT 93905844 T AT93905844 T AT 93905844T AT E145552 T1 ATE145552 T1 AT E145552T1
Authority
AT
Austria
Prior art keywords
compositions
delayed release
somatotropin
drugs
sprayed
Prior art date
Application number
AT93905844T
Other languages
English (en)
Inventor
Siva N Raman
Matthew W Gray
Rodger L Smith
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of ATE145552T1 publication Critical patent/ATE145552T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93905844T 1992-02-10 1993-02-09 Zusammensetzungen mit verzögerter wirkstoffabgabe ATE145552T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/833,197 US5328697A (en) 1992-02-10 1992-02-10 Compositions and processes for the sustained release of drugs

Publications (1)

Publication Number Publication Date
ATE145552T1 true ATE145552T1 (de) 1996-12-15

Family

ID=25263729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905844T ATE145552T1 (de) 1992-02-10 1993-02-09 Zusammensetzungen mit verzögerter wirkstoffabgabe

Country Status (13)

Country Link
US (1) US5328697A (de)
EP (1) EP0625900B1 (de)
JP (1) JPH08502020A (de)
CN (1) CN1071113C (de)
AT (1) ATE145552T1 (de)
AU (1) AU669884B2 (de)
CA (1) CA2129754A1 (de)
DE (1) DE69306243T2 (de)
DK (1) DK0625900T3 (de)
ES (1) ES2095045T3 (de)
NZ (1) NZ249658A (de)
TW (1) TW272133B (de)
WO (1) WO1993015725A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100210509B1 (ko) * 1996-01-10 1999-07-15 성재갑 지속성 동물 성장 호르몬 제형 및 이의 제조 방법
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
GB9910975D0 (en) * 1999-05-13 1999-07-14 Univ Strathclyde Rapid dehydration of proteins
CA2389236A1 (en) * 1999-11-02 2001-05-10 Depomed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
GB0116074D0 (en) * 2001-06-29 2001-08-22 Univ Strathclyde Nanoparticle structures
US7220433B2 (en) * 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
WO2005065673A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
DE102005060393A1 (de) * 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
FR3007651A1 (fr) * 2013-06-27 2015-01-02 Assist Publ Hopitaux De Paris Composition pharmaceutique sous forme de granules pour le traitement de desordres metaboliques chez l'enfant
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3220925A (en) * 1962-11-15 1965-11-30 Upjohn Co Tetracycline-novobiocin compositions and method of use
BE640616A (de) * 1962-12-19
US3383283A (en) * 1964-01-24 1968-05-14 Merck & Co Inc Medicinal pellets coated with overlapping porous fatty acid leaflet layers
US3365365A (en) * 1965-08-09 1968-01-23 Hoffmann La Roche Repeat action pharmaceutical compositions in the form of discrete beadlets
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung

Also Published As

Publication number Publication date
TW272133B (de) 1996-03-11
CN1071113C (zh) 2001-09-19
DK0625900T3 (da) 1997-06-02
DE69306243T2 (de) 1997-03-20
EP0625900A1 (de) 1994-11-30
DE69306243D1 (de) 1997-01-09
CA2129754A1 (en) 1993-08-11
US5328697A (en) 1994-07-12
WO1993015725A1 (en) 1993-08-19
AU3661093A (en) 1993-09-03
AU669884B2 (en) 1996-06-27
EP0625900B1 (de) 1996-11-27
JPH08502020A (ja) 1996-03-05
CN1075253A (zh) 1993-08-18
ES2095045T3 (es) 1997-02-01
NZ249658A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
ATE145552T1 (de) Zusammensetzungen mit verzögerter wirkstoffabgabe
ATE228825T1 (de) Orale dosierungsformen mit pulverschicht
RU94046268A (ru) Микрогранулы омепразола и способ их получения
MY113488A (en) Compounds with growth hormone releasing properties
IT1164156B (it) Inibitori dell'enzima che trasforma l'angiotensina,costituiti da acidi amminoalchilfosfinici e da acidi amminofosfinici sostituiti simili
EP0158277A3 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
DE68916996D1 (de) Anwuchsverhindernde Überzugszusammensetzung.
FI832053A7 (fi) LHRH-antagonistina käyttökelpoinen LHRH:n nonapeptidi- ja dekapeptidianalogit sekä niiden valmistusmenetevalmistusmenetelmä.
BG102259A (en) Compostions with controlled paroxetine release
DE58905460D1 (de) Verfahren zur Herstellung und Applikation von unter Feuchtigkeitseinwirkung nachvernetzenden Schmelzklebermassen.
ZA792124B (en) Novel spraying composition, method of applying the same article produced thereby
DE3763149D1 (de) Spruehkopf zur pulverbeschichtung.
DE69209080D1 (de) Pharmazeutische zusammemsetzungen mit verzoegerter freigabe
NO872260D0 (no) Fremgangsmaate for sliping av silisiumkarbid til pulver.
FI913592A7 (fi) Valmistustapoja verihiutaleiden aktivaation polypeptidi-inhibiittoreid en tuottamiseksi sekä menetelmiä, yhdistelmiä ja koostumuksia, joissa niitä käytetään
IL52936A (en) Coating ensuring a controlled release of active ingredients of biologically active compositions,particularly pharmaceutical compositions,its production and preparations having such a coating
EA200401488A1 (ru) Продукты с запуском начала действия и способы производства и использования таких продуктов
NO893088D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
PL337279A1 (en) Pharmaceutical with controlled releose containing inhibitor ace as an active substance
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
DE68920896D1 (de) N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung.
DE68907432D1 (de) Beschichtete granulierte duengemittelzusammensetzung und ihre herstellung.
MX9400072A (es) Agentes antiinflamatorios derivados de difluoropentapeptido.
IT8921513A0 (it) Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmacuetiche che li contengono.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties